Education, Science, Technology, Innovation and Life
Open Access
Sign In
  1. Home
  2. Journals
  3. MEDS Chinese Medicine
  4. Vol 5, Issue 5, 2023

Progress in Traditional Chinese and Western Medicine of Iga Nephropathy

Download as PDF

DOI: 10.23977/medcm.2023.050511 | Downloads: 22 | Views: 421

Author(s)

Juan Wang 1, Xiaoyong Yu 2

Affiliation(s)

1 Shaanxi University of Chinese Medicine, Xianyang, Shaanxi, 712046, China
2 Shaanxi Provincial Hospital of Traditional Chinese Medicine, Xi'an, Shaanxi, 710003, China

Corresponding Author

Xiaoyong Yu

ABSTRACT

IgA nephropathy is a renal disease characterized by glomerular IgA deposition, with proteinuria, hematuria, hypertension or renal impairment as the main clinical manifestations, and its incidence increases with age. At present, the cause of IgA nephropathy is not completely understood and there is no specific treatment. The pathogenesis and clinical treatment of Traditional Chinese medicine and western medicine have their own theories and advantages. Now the etiology and pathogenesis of IgA nephropathy and the treatment of Traditional Chinese medicine are reviewed, in order to provide theoretical basis and reference for the clinical treatment and research of IgA nephropathy.

KEYWORDS

IgA nephropathy; Traditional Chinese and Western medicine; Etiology and pathogenesis; Clinical treatment; Review

CITE THIS PAPER

Juan Wang, Xiaoyong Yu, Progress in Traditional Chinese and Western Medicine of Iga Nephropathy. MEDS Chinese Medicine (2023) Vol. 5: 73-81. DOI: http://dx.doi.org/10.23977/medcm.2023.050511.

REFERENCES

[1] Lin Qizhan, Ma Yupeng, Pan Biqi, et al. Professor Zhang Qi has an experience in urinary blood syndrome of IgA nephropathy [J]. Journal of Guangzhou University of Traditional Chinese Medicine, 2006, 5 (23): 234 26
[2] Nie Lifang. Traditional Chinese medicine treatment of urinary blood in IgA nephropathy [J]. Chinese Journal of Integrated Chinese and Western Medicine nephropathy, 2001, 2 (11): 62
[3] Chang T Y,  Wang Y P,  Wang H A, et al. Comparative efficacy and safety of traditional Chinese medicine for IgA nephropathy: A systematic review and meta-analysis[J]. European Journal of Integrative Medicine, 2021, 46:101372-. 
[4] Chen Hongtong, Gong Caidi, Xiong Chong, etc. Study on TCM syndrome and medication rule of IgA nephropathy based on data mining [J]. Journal of Hainan Medical College, 2021, 27 (12): 5. 
[5] Mao Liuyan, Li Juan, Zhuang Ji. Clinical study on the treatment of IgA nephropathy with combined traditional Chinese and Western medicine [J]. New Traditional Chinese Medicine, 2021. 
[6] Du Lanpin. Chen Yiping Chinese medicine experience in IgA nephropathy [J]. Liaoning Journal of Traditional Chinese Medicine, 2001, 28 (4): 204-205
[7] Huo Guangxu. Wang Yaoxian's experience of treating IgA nephropathy from Sanjiao [J]. Clinical Journal of Traditional Chinese Medicine, 2005, 17 (1): 76-78. 
[8] Li Han, Du Jinxing. Clinical experience in the treatment of IgA nephropathy [J]. Beijing Traditional Chinese Medicine, 2011, 30 (1): 28-29. 
[9] Knoppova B, Reily C, Maillard N, et al. The Origin and Activities of IgA1-Containing Immune Complexes in IgA Nephropathy [J]. Front Immunol, 2016, 7: 117. 
[10] Suzuki H, Raska M, Yamada K, et al. Cytokines alter IgA1 O-glycosylation by dysregulating C1 galT1 and ST6 galNAc-II enzymes [J]. J Biol Chem, 2014, 289(8): 5330-5339. 
[11] Canetta PA, Kiryluk K, Appel GB. Glomerular diseases: emerging tests and therapies for IgA nephropathy [J]. Clin J Am Soc Nephrol, 2014, 9(3): 617-625. 
[12] Magistroni R, Agati D, V D, et al. New developments in the genetics, pathogenesis, and therapy of IgA nephropathy. Kidney Int, 2015, 88: 974-989. 
[13] Zhao Bingru, Gu Leyi, Dai Huili. Progress in genetic factors and biomarkers associated to IgA nephropathy [J]. Chinese Journal of Integrated Traditional Chinese and Western Medicine nephropathy, 2020, 21 (02): 180-183. 
[14] Pei Y, Xu Y, Ruan J, et al. Plasma oxidative stress level of IgA nephropathy in children and the effect of early intervention with angiotensin-converting enzyme inhibitors[J]. J Renin Angiotensin Aldosterone Syst, 2016, 17(2): 1470320316647240. 
[15] Cheng J, Zhang X, Tian J, et al. Combination therapy an ACE inhibitor and an angiotensin receptor blocker for IgA nephropathy : a meta - analysis[J]. Int J Clin Pract, 2012, 66( 10) : 917-923. 
[16] Yuzawa Y, Yamamoto R, Takahashi K, et al. Evidencebased clinical practice guidelines for Ig A nephropathy 2014 [S]. Clin Exp Nephrol, 2016, 20( 4) : 511-535. 
[17] Wang Haiyan, Lu Jicheng, Zhang Hong. To evaluate the treatment plan of adult IgA nephropathy from the perspective of evidence-based medicine [J]. Chinese Journal of Internal Medicine, 2004, 43 (9): 712 714. 
[18] Zhu Mingzhi, Zhong Ruiqiong, Tong Yu. Analysis of the effect of different treatment options applied in patients with IgA nephropathy [J]. Journal of Clinical Nephrology, 2019, 19 (7): 512-515. 
[19] Wang Weiping, Zhang Yuqiang. Clinical analysis of IgA nephropathy with leflunomide treatment with refractory nephrotic syndrome [J]. Chinese Journal of Integrated Chinese and Western Medicine, 2010, 11 (10): 906-908. 
[20] Yang Y, Chen Y, Li Z, et al. Effects of huangqin zhizi tang combined with irbesartan on renal function and urinary excretion of inflammatory factors in patients with diabetic nephropathy. Chin J Integr Med. 2018; 24(2):136-141. 
[21] Dong Moyang, Ding Tingting, Rao Xiangrong, Lu Jicheng, Li Jinpu, Li Shen. Qi-clearing prescription and immunosuppressants for high-risk IgA nephropathy [J]. Chinese Journal of Integrated Traditional Chinese and Western Medicine, 2019, 39 (07): 791-797. 

Subscription
E-Mail Alert
Most popular papers
Call for Special Issue
Publication Ethics & OA Statement
Plagiarism Policy
Contact Us
Downloads: 4220
Visits: 166931

Sponsors, Associates, and Links

All published work is licensed under a Creative Commons Attribution 4.0 International License.

Copyright © 2016 - 2031 Clausius Scientific Press Inc. All Rights Reserved.